Market Overview

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)

117.96 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2020
Pre-Market
EPS:
REV:
-1.50
70.061M



Q2 2020
Pre-Market
EPS:
REV:




Q1 2020
Pre-Market
EPS:
REV:
-1.73
33.294M



Q4 2019
After-Hours
EPS:
REV:
-1.82
21.033M



Q3 2019
Pre-Market
EPS:
REV:
-1.56
2.069M

-1.50
70.061M

Q2 2019
Pre-Market
EPS:
REV:
-1.61
29.907M
-1.86
69.2M
-1.83
44.714M
1.61%
-35.38%
Q1 2019
Pre-Market
EPS:
REV:
-1.22
21.899M
-2.07
23.65M
-1.73
33.294M
16.43%
40.78%
Q4 2018
After-Hours
EPS:
REV:
-1.20
37.924M
-2.28
15.19M
-1.82
21.033M
-20.18%
38.47%
Q3 2018
Pre-Market
EPS:
REV:
-1.06
17.096M
-2.01
18.23M
-1.56
2.069M
-22.39%
-88.65%
Q2 2018
Pre-Market
EPS:
REV:
-1.34
15.932M
-1.77
17.97M
-1.61
29.907M
-9.04%
66.43%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!